華業香料(300886.SZ):擬使用總額度不超7000萬元暫時閒置自有資金進行現金管理
格隆匯9月25日丨華業香料(300886.SZ)公佈,公司於2020年9月23日召開第三屆董事會第十四次會議和第三屆監事會第十一次會議,審議通過了《關於使用部分閒置自有資金進行現金管理的議案》,同意公司(含全資子公司)擬在不影響正常經營和保證資金安全的情況下,使用總額度不超過7000萬元(含7000萬元)的暫時閒置自有資金進行現金管理,使用期限自本次董事會審議通過之日起12個月內有效。
在前述資金額度和有效期內,資金可以循環滾動使用,並同意授權公司經營管理層在前述資金額度和有效期內行使該項投資決策權並簽署相關合同及文件,公司財務部負責組織實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.